Been CYDY investor since late 2016 and this is lik
Post# of 148165
(Total Views: 461)
Posted On: 12/21/2022 5:27:01 PM
Been CYDY investor since late 2016 and this is like deja vu all over again. A fantastic opportunity to buy what we know to be a once in lifetime drug- for TWO dimes!
With mature seasoned adults across the board now running the company, we've traded Johnny Manziel for Patrick Mahomes and don't forget Big Pharma will spend like the Kardashians rampaging through Tiffany's if they catch a whiff of future profit.
Approximately three years ago Gilead paid $5 Billion for CD-47 monoclonal antibody Magrolimab that showed "promise" and hasn't been able to steer it through successful trials yet- and a press release today shared that Jazz Pharma paid $325 million upfront to partner with Zymeworks on development of their antibody called Zanidatamab. Leronlimab is superior and one day in the not too distant future I expect to read the same type headline.
As for Amarex, I have no doubt they are culpable in this debacle. Whatever the profession, when you sign a work contract the client ( no matter what the client instructs them to do) has the expectation of trust, fiduciary duty, fair practice and certainly a minimal standard of competence and ethical behavior. And Amarex missed on all counts.
As for NP, he revealed his own true self and could be looking at extended prison sentence if convicted. His shadow hangs over the company today, but it will fade in time. Wouldn't surprise me if he flees the country.
I'l be buying again in the morning- GLTA
With mature seasoned adults across the board now running the company, we've traded Johnny Manziel for Patrick Mahomes and don't forget Big Pharma will spend like the Kardashians rampaging through Tiffany's if they catch a whiff of future profit.
Approximately three years ago Gilead paid $5 Billion for CD-47 monoclonal antibody Magrolimab that showed "promise" and hasn't been able to steer it through successful trials yet- and a press release today shared that Jazz Pharma paid $325 million upfront to partner with Zymeworks on development of their antibody called Zanidatamab. Leronlimab is superior and one day in the not too distant future I expect to read the same type headline.
As for Amarex, I have no doubt they are culpable in this debacle. Whatever the profession, when you sign a work contract the client ( no matter what the client instructs them to do) has the expectation of trust, fiduciary duty, fair practice and certainly a minimal standard of competence and ethical behavior. And Amarex missed on all counts.
As for NP, he revealed his own true self and could be looking at extended prison sentence if convicted. His shadow hangs over the company today, but it will fade in time. Wouldn't surprise me if he flees the country.
I'l be buying again in the morning- GLTA
(10)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼